Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Xtep International (1368.HK)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (HK$) Price Target (HK$) Rating
2022-02-2812.90-No Rating
2022-09-1310.5614.00Buy
2022-10-188.0512.70Buy
2022-11-159.8412.20Buy
2023-02-209.4412.00Buy
2023-03-239.0812.30Buy
2023-04-119.9012.50Buy
2023-07-177.8710.80Buy
2023-10-167.0810.40Buy
2023-11-136.439.40Buy
2023-12-184.358.64Buy
2024-01-063.784.10Neutral
2024-04-184.464.50Neutral
2025-01-135.515.80Neutral
2025-03-195.556.00Neutral
2025-04-184.905.44Neutral
2025-05-286.205.78Neutral

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.